Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.
about
Biolabile peptidyl delivery systems toward sequential drug release.Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaExploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.99m Tc-labeled NGR-chlorambucil conjugate, 99m Tc-HYNIC-CLB-c(NGR) for targeted chemotherapy and molecular imaging.Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.
P2860
Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synthesis, drug release, and b ...... analog as a targeting moiety.
@en
type
label
Synthesis, drug release, and b ...... analog as a targeting moiety.
@en
prefLabel
Synthesis, drug release, and b ...... analog as a targeting moiety.
@en
P2093
P2860
P356
P1433
P1476
Synthesis, drug release, and b ...... analog as a targeting moiety.
@en
P2093
Albeck Amnon
Bazylevich Andreii
Boris Redko
Elena Ragozin
Gellerman Gary
Kostenich Genady
Oron-Herman Mor
Shekhter Zahavi Talia
Tuchinsky Helena
P2860
P304
P356
10.1002/BIP.22694
P577
2015-06-08T00:00:00Z